/r/LungCancerSupport

Year:

Only show posts with narrations

Sublobar Resection vs Lobectomy for High-Risk Stage I Non–Small Cell Lung Carcinoma

1 upvotes • WalkingHorse

Mark as read: Add to a list

Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center

1 upvotes • WalkingHorse

Mark as read: Add to a list

Antibody–drug conjugates treatment of small cell lung cancer: advances in clinical research

1 upvotes • WalkingHorse

Mark as read: Add to a list

Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial

1 upvotes • WalkingHorse

Mark as read: Add to a list

Emerging role of sirtuins in non‑small cell lung cancer (Review)

1 upvotes • WalkingHorse

Mark as read: Add to a list

Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer

1 upvotes • WalkingHorse

Mark as read: Add to a list

A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib

1 upvotes • WalkingHorse

Mark as read: Add to a list

Analysis of surgical complexity and short-term prognostic indicators in NSCLC patients: neoadjuvant targeted therapy versus neoadjuvant chemoimmunotherapy

1 upvotes • WalkingHorse

Mark as read: Add to a list

Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report

1 upvotes • WalkingHorse

Mark as read: Add to a list

Pseudoprogression following neoadjuvant chemoimmunotherapy for lung squamous cell carcinoma mimicking pulmonary metastatic disease on computed tomography: A case report and review of the literature

1 upvotes • WalkingHorse

Mark as read: Add to a list

Title	Upvotes	Author	Mark as read	Favorited	Rating	Add to a list
Sublobar Resection vs Lobectomy for High-Risk Stage I Non–Small Cell Lung Carcinoma	1	WalkingHorse
Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center	1	WalkingHorse
Antibody–drug conjugates treatment of small cell lung cancer: advances in clinical research	1	WalkingHorse
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial	1	WalkingHorse
Emerging role of sirtuins in non‑small cell lung cancer (Review)	1	WalkingHorse
Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer	1	WalkingHorse
A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib	1	WalkingHorse
Analysis of surgical complexity and short-term prognostic indicators in NSCLC patients: neoadjuvant targeted therapy versus neoadjuvant chemoimmunotherapy	1	WalkingHorse
Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report	1	WalkingHorse
Pseudoprogression following neoadjuvant chemoimmunotherapy for lung squamous cell carcinoma mimicking pulmonary metastatic disease on computed tomography: A case report and review of the literature	1	WalkingHorse